- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Too Big To Fail
Chinese Pharmaceuticals & Biotech Too Big To Fail
Results
4
Large established companies which pay a dividend.
4 companies
Sichuan Kelun Pharmaceutical
Market Cap: CN¥58.7b
Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China.
002422
CN¥36.87
7D
-5.8%
1Y
22.7%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥48.4b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥29.10
7D
-2.0%
1Y
3.9%
Livzon Pharmaceutical Group
Market Cap: CN¥33.9b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥40.32
7D
-0.7%
1Y
14.2%
Tasly Pharmaceutical Group
Market Cap: CN¥23.9b
Engages in the pharmaceutical business in China and internationally.
600535
CN¥15.98
7D
-2.1%
1Y
16.0%